SUN PHARMACEUTICAL INDUSTRIES LTD. 2024-2025 Proxy Voting Records

The 42 asset managers below reported 83,802,568 for, 3,755,652 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Description as filed by funds: APPOINTMENT OF MR. DILIP SHANGHVI AS A DIRECTOR, LIABLE TO RETIRE BY ROTATION

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

The 44 asset managers below reported 89,792,290 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).

Description as filed by funds: RESOLVED THAT PURSUANT TO THE PROVISIONS OF SECTIONS 230 TO 232 OF THE COMPANIES ACT, 2013 AND OTHER APPLICABLE PROVISIONS, IF ANY, OF THE COMPANIES ACT, 2013 (HEREINAFTER REFERRED AS ACT) READ WITH THE COMPANIES (COMPROMISES, ARRANGEMENTS AND AMALGAMATIONS) RULES, 2016 (INCLUDING ANY STATUTORY MODIFICATION(S) OR RE-ENACTMENT THEREOF FOR THE TIME BEING IN FORCE), SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 AND THE CLAUSES OF THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF SUN PHARMACEUTICAL INDUSTRIES LIMITED AND SUBJECT TO THE APPROVAL OF THE NATIONAL COMPANY LAW TRIBUNAL (NCLT) AND SUCH OTHER STATUTORY APPROVALS INCLUDING BUT NOT LIMITED TO APPROVAL OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (SEBI), STOCK EXCHANGES, RESERVE BANK OF INDIA, AS MAY BE REQUIRED AND SUBJECT TO SUCH CONDITIONS AND MODIFICATIONS AS MAY BE PRESCRIBED OR IMPOSED BY NCLT OR BY ANY REGULATORY OR OTHER AUTHORITIES, WHILE GRANTING SUCH CONSENTS, APPROVALS, PERMISSIONS AND SANCTIONS, WHICH MAY BE AGREED TO BY THE BOARD OF DIRECTORS OF THE COMPANY (HEREINAFTER REFERRED TO AS THE BOARD, WHICH TERM SHALL BE DEEMED TO MEAN AND INCLUDE ONE OR MORE COMMITTEE(S) CONSTITUTED/TO BE CONSTITUTED BY THE BOARD OR ANY OTHER PERSON(S) WHICH THE BOARD MAY NOMINATE TO EXERCISE ITS POWERS INCLUDING THE POWERS CONFERRED BY THIS RESOLUTION), APPROVAL OF THE EQUITY SHAREHOLDERS OF SUN PHARMACEUTICAL INDUSTRIES LIMITED BE AND IS HEREBY ACCORDED FOR THE COMPOSITE SCHEME OF ARRANGEMENT (HEREINAFTER REFERRED TO AS SCHEME OF ARRANGEMENT OR SCHEME), WITH THEIR RESPECTIVE SHAREHOLDERS, INVOLVING: (A) AMALGAMATION OF WHOLLY-OWNED SUBSIDIARY COMPANIES VIZ. SUN PHARMACEUTICAL MEDICARE LIMITED, GREEN ECO DEVELOPMENT CENTRE LIMITED, FASTSTONE MERCANTILE COMPANY PRIVATE LIMITED, REALSTONE MULTITRADE PRIVATE LIMITED, SKISEN LABS PRIVATE LIMITED WITH SUN PHARMACEUTICAL INDUSTRIES LIMITED (COMPANY), AND (B) RECLASSIFICATION OF GENERAL RESERVE OF THE COMPANY TO RETAINED EARNINGS; RESOLVED FURTHER THAT ANY ONE OF THE WHOLE-TIME DIRECTORS, CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY AND COMPLIANCE OFFICER OF THE COMPANY, BE AND ARE HEREBY SEVERALLY AUTHORISED TO DO ALL SUCH ACTS, DEEDS, MATTERS AND THINGS AS MAY BE NECESSARY TO GIVE EFFECT TO THIS RESOLUTION INCLUDING BUT NOT LIMITED TO SEEKING ANY DIRECTIONS OF NCLT OR ANY OTHER STATUTORY AUTHORITY/ REGULATOR AND TO TAKE ALL STEPS NECESSARY TO EFFECTIVELY IMPLEMENT THE ARRANGEMENTS EMBODIED IN THE SCHEME OF ARRANGEMENT AND TO MAKE ANY MODIFICATIONS OR AMENDMENTS TO THE SCHEME AT ANY TIME AND FOR ANY REASON WHATSOEVER, AND TO ACCEPT SUCH MODIFICATIONS, AMENDMENTS, LIMITATIONS AND/OR CONDITIONS, IF ANY, WHICH MAY BE REQUIRED AND/OR IMPOSED BY THE NCLT AND/OR ANY OTHER AUTHORITY(IES) WHILE SANCTIONING THE SCHEME OF ARRANGEMENT OR BY ANY AUTHORITY(IES) UNDER LAW, OR AS MAY BE REQUIRED FOR THE PURPOSE OF RESOLVING ANY QUESTIONS OR DOUBTS OR DIFFICULTIES THAT MAY ARISE INCLUDING PASSING OF SUCH ACCOUNTING ENTRIES AND/OR MAKING SUCH ADJUSTMENTS IN THE BOOKS OF ACCOUNTS AS CONSIDERED NECESSARY IN GIVING EFFECT TO THE SCHEME OF ARRANGEMENT, AS ANY ONE OF THE WHOLE-TIME DIRECTORS, CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY AND COMPLIANCE OFFICER MAY DEEM FIT AND PROPER WITHOUT BEING REQUIRED TO SEEK ANY FURTHER APPROVAL OF THE MEMBERS OR OTHERWISE TO THE END AND INTENT THAT THE MEMBERS SHALL BE DEEMED TO HAVE GIVEN THEIR APPROVAL THERETO EXPRESSLY BY THE AUTHORITY OF THIS RESOLUTION

The 11 asset managers below reported 26,726,228 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

The 42 asset managers below reported 87,558,220 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

The 42 asset managers below reported 87,558,220 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

The 42 asset managers below reported 87,558,220 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Description as filed by funds: ADOPTION OF CONSOLIDATED FINANCIAL STATEMENT

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: ADOPTION OF STANDALONE FINANCIAL STATEMENTS

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: TO DECLARE FINAL DIVIDEND OF INR 5/- (RUPEES FIVE ONLY) PER EQUITY SHARE OF INR 1/- EACH (RUPEE ONE ONLY) FOR THE FINANCIAL YEAR 2023-24

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: Approve Material Related Party Transactions between Taro Pharmaceutical Industries Ltd., Israel and Sun Pharmaceutical Industries Inc., USA

The 45 asset managers below reported 90,646,413 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Description as filed by funds: Approve Material Related Party Transactions between Taro Pharmaceuticals Inc., Canada and Sun Pharmaceutical Industries Inc., USA

The 45 asset managers below reported 90,646,413 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Description as filed by funds: Approve Material Related Party Transactions between Taro Pharmaceuticals U.S.A., Inc., USA and Sun Pharmaceutical Industries Inc., USA

The 45 asset managers below reported 90,646,413 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Description as filed by funds: Approve Material Related Party Transactions between Taro Pharmaceutical Industries Limited, Israel and Taro Pharmaceuticals USA, Inc

The 42 asset managers below reported 87,558,220 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

The 42 asset managers below reported 87,558,220 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Description as filed by funds: APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS BETWEEN TARO PHARMACEUTICAL INDUSTRIES LTD., ISRAEL AND SUN PHARMACEUTICAL INDUSTRIES INC., USA

The 11 asset managers below reported 26,378,323 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS BETWEEN TARO PHARMACEUTICALS INC., CANADA AND SUN PHARMACEUTICAL INDUSTRIES INC., USA

The 11 asset managers below reported 26,378,323 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS BETWEEN TARO PHARMACEUTICALS U.S.A., INC., USA AND SUN PHARMACEUTICAL INDUSTRIES INC., USA

The 11 asset managers below reported 26,378,323 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS BETWEEN TARO PHARMACEUTICAL INDUSTRIES LIMITED, ISRAEL AND TARO PHARMACEUTICALS USA, INC FOR THE FINANCIAL YEAR 2024-25

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS BETWEEN TARO PHARMACEUTICALS INC, CANADA AND TARO PHARMACEUTICALS USA, INC FOR THE FINANCIAL YEAR 2024-25

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

The 42 asset managers below reported 87,558,220 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Description as filed by funds: RATIFICATION OF THE REMUNERATION OF THE COST AUDITOR FOR FINANCIAL YEAR 2024-25

The 8 asset managers below reported 28,183,530 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.